Biogen Price Chart
Biogen Volume Chart
Biogen Market Segments
Regular Trading Hours
| Open | $210.99 |
|---|---|
| Close | $213.68 |
| Low | $210.01 |
| Low Change | -0.98 (-0.46%) |
| High | $214.07 |
| High Change | +3.08 (+1.46%) |
| Range | $4.06 |
| Volume | 368.989K |
| Dollar Volume | $78.84M |
Premarket
| Open | $209.98 |
|---|---|
| Close | $209.98 |
| Low | $209.98 |
| Low Change | 0.00 (0.00%) |
| High | $209.98 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $21.00K |
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $209.15 |
|---|---|
| Close | $209.15 |
| Low | $209.15 |
| Low Change | 0.00 (0.00%) |
| High | $209.15 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 150.578K |
| Dollar Volume | $31.49M |
Regular Trading Hours Yesterday
| Open | $208.36 |
|---|---|
| Close | $209.15 |
| Low | $207.62 |
| Low Change | -0.74 (-0.36%) |
| High | $210.49 |
| High Change | +2.13 (+1.02%) |
| Range | $2.87 |
| Volume | 439.993K |
| Dollar Volume | $92.02M |
Premarket Yesterday
| Open | $209.00 |
|---|---|
| Close | $207.94 |
| Low | $207.94 |
| Low Change | -1.06 (-0.51%) |
| High | $209.00 |
| High Change | +0.00 (+0.00%) |
| Range | $1.06 |
| Volume | 750 |
| Dollar Volume | $155.96K |
Biogen News
5 days agoinvesting.comWolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- 3 weeks agoinvesting.com
Biogen beats quarterly estimates as newer drugs fuel growth
- 1 month agoinvesting.com
Biogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
- 1 month agoinvesting.com
Biogen stock rises on positive Alzheimer’s drug trial data
1 month agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
- 1 month agoinvesting.com
Why is Biogen stock rallying today?
- 1 month agoinvesting.com
Truist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key data
- 1 month agobarrons.com
Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details
- 1 month agobarrons.com
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
- 3 months agoinvesting.com
Biogen advances Alzheimer’s drug after mid-stage trial results
Biogen Top Trades
Biogen's top trade so far today returned +1.95%, while the top short trade returned -0.46%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $208.50 |
|---|---|
| 10 Day Moving Average (SMA10) | $207.89 |
| 20 Day Moving Average (SMA20) | $205.56 |
| 50 Day Moving Average (SMA50) | $203.63 |
| 100 Day Moving Average (SMA100) | $195.59 |
| 200 Day Moving Average (SMA200) | $186.69 |
Biogen Statistics
| Average Volume (30 Days) | 1.27M |
|---|---|
| P/E Ratio (Current) | 37.14 |
| EPS (Current) | $5.65 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.70B |
| Cash Ratio | 0.33 |
| Current Ratio | 1.87 |
| Quick Ratio | 1.26 |
| Debt to Equity | 0.43 |
| Enterprise Value | $37.81B |
| EV to EBITDA | 16.43 |
| EV to Sales | 3.77 |
| Price to Book | 1.64 |
| Price to Cash Flow | 10.77 |
| Price to Free Cash Flow | 11.50 |
| Price to Sales | 3.09 |
| Return on Assets | 0.03% |
| Return on Equity | 0.04% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).